A detailed history of American Financial Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, American Financial Advisors, LLC holds 806 shares of AMGN stock, worth $212,953. This represents 0.04% of its overall portfolio holdings.

Number of Shares
806
Previous 1,510 46.62%
Holding current value
$212,953
Previous $471,000 45.01%
% of portfolio
0.04%
Previous 0.07%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$309.38 - $337.38 $217,803 - $237,515
-704 Reduced 46.62%
806 $259,000
Q2 2024

Jul 24, 2024

BUY
$262.75 - $319.31 $1,313 - $1,596
5 Added 0.33%
1,510 $471,000
Q1 2024

Apr 22, 2024

BUY
$268.87 - $324.56 $81,736 - $98,666
304 Added 25.31%
1,505 $427,000
Q4 2023

Jan 31, 2024

BUY
$255.7 - $288.46 $7,159 - $8,076
28 Added 2.39%
1,201 $345,000
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $1,749 - $2,171
8 Added 0.69%
1,173 $315,000
Q2 2023

Jul 13, 2023

BUY
$214.27 - $253.37 $2,785 - $3,293
13 Added 1.13%
1,165 $258,000
Q1 2023

Apr 18, 2023

BUY
$225.79 - $275.2 $2,032 - $2,476
9 Added 0.79%
1,152 $278,000
Q4 2022

Jan 26, 2023

BUY
$229.03 - $291.01 $687 - $873
3 Added 0.26%
1,143 $0
Q3 2022

Oct 17, 2022

BUY
$224.46 - $253.15 $255,884 - $288,591
1,140 New
1,140 $257,000
Q2 2022

Aug 01, 2022

SELL
$230.71 - $256.74 $260,933 - $290,372
-1,131 Closed
0 $0
Q1 2022

Apr 27, 2022

BUY
$219.27 - $242.57 $11,402 - $12,613
52 Added 4.82%
1,131 $273,000
Q4 2021

Feb 02, 2022

BUY
$198.88 - $227.6 $214,591 - $245,580
1,079 New
1,079 $243,000
Q3 2021

Nov 05, 2021

SELL
$212.27 - $248.7 $189,981 - $222,586
-895 Closed
0 $0
Q2 2021

Aug 05, 2021

BUY
$233.58 - $259.14 $467 - $518
2 Added 0.22%
895 $218,000
Q1 2021

May 13, 2021

BUY
$221.91 - $258.6 $198,165 - $230,929
893 New
893 $222,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track American Financial Advisors, LLC Portfolio

Follow American Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on American Financial Advisors, LLC with notifications on news.